SCHEMBL6574977

SCHEMBL6574977

CCCOC(CN)OCCC

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 1/20 0.39
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11596188 0.87
SCHEMBL2023113 0.83 DNM1 (0.52) DNM1CA1CA2HTT
SCHEMBL10780852 0.81 DNM1 (0.61) DNM1CA1CA2HTT
SCHEMBL11597777 0.79 DNM1 (0.65) DNM1CA1CA2HTT
SCHEMBL6575134 0.78 CA1 (0.33) DNM1CA1CA2
SCHEMBL16281634 0.78 TSHR (0.34) DNM1CA1CA2HTT
SCHEMBL10430663 0.77 CA1 (0.31) DNM1CA1CA2
SCHEMBL289118 0.75
SCHEMBL11381692 0.75 CA1 (0.33) CA1CA2
SCHEMBL4425572 0.75 CA1 (0.33) CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110317212-B Synthesis of polycyclic carbamoylpyridone compounds 吉利德科学公司 2022-10-21 CN claimed
EP-3527573-B9 SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS GILEAD SCIENCES INC (US) 2022-07-06 EP claimed
US-10975096-B2 Synthesis of polycyclic-carbamoylpyridone compounds GILEAD SCIENCES, INC. (US) 2021-04-13 US claimed
EP-3783001-A1 SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS Gilead Sciences, Inc. (US) 2021-02-24 EP claimed
EP-3527573-B1 SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS GILEAD SCIENCES INC (US) 2020-08-12 EP claimed
US-20200223866-A1 SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS GILEAD SCIENCES, INC. 2020-07-16 US claimed
EP-3527573-A1 SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS Gilead Sciences, Inc. (US) 2019-08-21 EP claimed
EP-3148674-B1 ABSORBENT SOLUTION CONTAINING A MIXTURE OF 1,2-BIS-(2-DIMETHYLAMINOETHOXY)-ETHANE AND 2-[2-(2- DIMETHYLAMINOETHOXY)-ETHOXY]-ETHANOL, AND METHOD FOR ELIMINATING ACID COMPOUNDS FROM A GAS EFFLUENT IFP ENERGIES NOW (FR) 2018-07-11 EP claimed
US-9962645-B2 Absorbent solution containing a mixture of 1,2-bis-(2-dimethylaminoethoxy)-ethane and of 2-[2-(2-dimethylaminoethoxy)-ethoxy]-ethanol, and method of removing acid compounds from a gaseous effluent IFP Energies Nouvelles (FR) 2018-05-08 US claimed
US-20170197176-A1 ABSORBENT SOLUTION CONTAINING A MIXTURE OF 1,2-BIS-(2-DIMETHYLAMINOETHOXY)-ETHANE AND OF 2-[2-(2-DIMETHYLAMINOETHOXY)-ETHOXY]-ETHANOL, AND METHOD OF REMOVING ACID COMPOUNDS FROM A GASEOUS EFFLUENT IFP Energies Nouvelles (FR) 2017-07-13 US claimed
CN-110317212-B Synthesis of polycyclic carbamoylpyridone compounds 吉利德科学公司 2022-10-21 CN disclosed
EP-3527573-B9 SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS GILEAD SCIENCES INC (US) 2022-07-06 EP disclosed
CN-114394983-A Synthesis of polycyclic carbamoylpyridone compounds 吉利德科学公司 2022-04-26 CN disclosed
US-10975096-B2 Synthesis of polycyclic-carbamoylpyridone compounds GILEAD SCIENCES, INC. (US) 2021-04-13 US disclosed
EP-3783001-A1 SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS Gilead Sciences, Inc. (US) 2021-02-24 EP disclosed
US-4792630-A REACTING HALOGENOACETALDEHYDE DIALKYLACETAL WITH AMMONIA OR ALKYLAMINE NIPPON GOSEI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1988-12-20 US disclosed
US-4769480-A Benzylamine derivative MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1988-09-06 US disclosed
EP-0214051-A2 Benzylamine derivative MITSUBISHI KASEI CORPORATION (JP) 1987-03-11 EP disclosed
US-4118216-A HERBICIDES VELSICOL CHEMICAL COMPANY (US) 1978-10-03 US disclosed
US-4097491-A HERBICIDES VELSICOL CHEMICAL CORPORATION (US) 1978-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200223866-A1 SYNTHESIS OF POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS CPS1, SDHA, DHPS DNM1 1895/4885CA1 764/4885CA2 880/4885
US-10975096-B2 Synthesis of polycyclic-carbamoylpyridone compounds CPS1, SDHA, DHPS DNM1 1895/4885CA1 764/4885CA2 880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.